Changes to the Code
H.R. 693 · Restoring Confidence in the World Anti-Doping Agency Act of 2025 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
21 U.S.C. § 2001 Designation of United States Anti-Doping Agency
9 changes the bill asks for here, 8 carried out
- Carried out:
by amending paragraph (1) to read as follows:
(1) United States Olympic and Paralympic Committee.— The term “United States Olympic and Paralympic Committee” means the organization established by chapter 2205 of title 36, United States Code.;
- Carried out:
in paragraph (3), by striking
(36 U.S.C. 22501(b)(1))
and inserting(36 U.S.C. 220501(b)(1))
; - Carried out:
by redesignating paragraphs (1) and (3) as paragraphs (4) and (1), respectively, and moving the paragraphs so as to appear in numeric order; and
- Not carried out:
by redesignating paragraphs (1) and (3) as paragraphs (4) and (1), respectively, and moving the paragraphs so as to appear in numeric order; and
We can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: moving the paragraphs so as to appear in numeric order; and - Carried out:
by inserting after paragraph (2) the following:
(3) Independent athlete.— The term “independent athlete” means an Olympic or Paralympic athlete who does not serve, in any capacity— (A) on the International Olympic Committee; (B) on the International Paralympic Committee; (C) at an international sports federation recognized by …
- Carried out:
by striking
United States Olympic Committee
each place it appears and insertingUnited States Olympic and Paralympic Committee
; - Carried out:
in paragraph (5), by striking the period at the end and inserting
; and
; and - Carried out:
by adding at the end the following:
(6) carry out responsibilities with respect to the World Anti-Doping Agency, as described in subsection (d).; and
- Carried out:
by adding at the end the following:
(d) Authority with respect to the World Anti-Doping Agency.— (1) In general.— The Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes’ Commission, shall— …
§ 2001(a)–(b)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 2001. Designation of United States Anti-Doping Agency | § 2001. Designation of United States Anti-Doping Agency | |||
| (a) | (a) Definitions | (a) Definitions | ||
| In this subchapter: | In this subchapter: | |||
| (a)(4) | [inserted: (4)] United States Olympic [inserted: and Paralympic ]Committee[inserted: .—] | |||
| The term “United States Olympic Committee” means the organization established by | The term “United States Olympic [inserted: and Paralympic ]Committee” means the organization established by [inserted: chapter] [inserted: 2205] [inserted: of] [inserted: title] 36[inserted: ,] [inserted: United] [inserted: States] [inserted: Code]. | |||
| (a)(2) | (2) Amateur athletic competition | (2) Amateur athletic competition | ||
| The term “amateur athletic competition” means a contest, game, meet, match, tournament, regatta, or other event in which amateur athletes compete (36 U.S.C. 220501(b)(2)). | The term “amateur athletic competition” means a contest, game, meet, match, tournament, regatta, or other event in which amateur athletes compete (36 U.S.C. 220501(b)(2)). | |||
| (a)(3) | (3) [inserted: Independent athlete.—] | |||
| [inserted: The term “independent athlete” means an Olympic or Paralympic athlete who does not serve, in any capacity—] | ||||
| (a)(3)(A) | (A) [inserted: ] | |||
| [inserted: on the International Olympic Committee;] | ||||
| (a)(3)(B) | (B) [inserted: ] | |||
| [inserted: on the International Paralympic Committee;] | ||||
| (a)(3)(C) | (C) [inserted: ] | |||
| [inserted: at an international sports federation recognized by the International Olympic Committee or the International Paralympic Committee;] | ||||
| (a)(3)(D) | (D) [inserted: ] | |||
| [inserted: on the United States Olympic and Paralympic Committee; or] | ||||
| (a)(3)(E) | (E) [inserted: ] | |||
| [inserted: at the World Anti-Doping Agency.] | ||||
| (a)(1) | [inserted: (1)] Amateur athlete | |||
| The term “amateur athlete” means an athlete who meets the eligibility standards established by the national governing body or paralympic sports organization for the sport in which the athlete competes (36 U.S.C. | The term “amateur athlete” means an athlete who meets the eligibility standards established by the national governing body or paralympic sports organization for the sport in which the athlete competes (36 U.S.C. [inserted: 220501](b)(1)). | |||
| (b) | (b) In general | (b) In general | ||
| The United States Anti-Doping Agency shall— | The United States Anti-Doping Agency shall— | |||
| (b)(1) | (1) | (1) | ||
§ 2001(b)–(d)
(b)(1)(A)–(B) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (b)(1)(C) | (C) | (C) | ||
| be recognized worldwide as the independent national anti-doping organization for the United States; | be recognized worldwide as the independent national anti-doping organization for the United States; | |||
| (b)(2) | (2) | (2) | ||
| ensure that athletes participating in amateur athletic activities recognized by the United States Olympic Committee are prevented from using performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency; | ensure that athletes participating in amateur athletic activities recognized by the United States Olympic [inserted: and Paralympic ]Committee are prevented from using performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency; | |||
| (b)(3) | (3) | (3) | ||
| implement anti-doping education, research, testing, and adjudication programs to prevent United States Amateur Athletes participating in any activity recognized by the United States Olympic Committee from using performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency; | implement anti-doping education, research, testing, and adjudication programs to prevent United States Amateur Athletes participating in any activity recognized by the United States Olympic [inserted: and Paralympic ]Committee from using performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency; | |||
| (b)(4) | (4) | (4) | ||
| serve as the United States representative responsible for coordination with other anti-doping organizations coordinating amateur athletic competitions recognized by the United States Olympic Committee to ensure the integrity of athletic competition, the health of the athletes, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency; and | serve as the United States representative responsible for coordination with other anti-doping organizations coordinating amateur athletic competitions recognized by the United States Olympic [inserted: and Paralympic ]Committee to ensure the integrity of athletic competition, the health of the athletes, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency; and | |||
| (b)(5) | (5) | (5) | ||
| promote a positive youth sport experience by using a portion of the funding of the United States Anti-Doping Agency to provide educational materials on sportsmanship, character building, and healthy performance for the athletes, parents, and coaches who participate in youth sports | promote a positive youth sport experience by using a portion of the funding of the United States Anti-Doping Agency to provide educational materials on sportsmanship, character building, and healthy performance for the athletes, parents, and coaches who participate in youth sports[inserted: ; and] | |||
| (b)(6) | (6) [inserted: ] | |||
| [inserted: carry out responsibilities with respect to the World Anti-Doping Agency, as described in subsection (d).] | ||||
| (c) | (c) Due process in arbitration proceedings | (c) Due process in arbitration proceedings | ||
| Any action taken by the United States Anti-Doping Agency to enforce a policy, procedure, or requirement of the United States Anti-Doping Agency against a person with respect to a violation of Federal law, including an investigation, a disciplinary action, a sanction, or any other administrative action, shall be carried out in a manner that provides due process protection to the person. | Any action taken by the United States Anti-Doping Agency to enforce a policy, procedure, or requirement of the United States Anti-Doping Agency against a person with respect to a violation of Federal law, including an investigation, a disciplinary action, a sanction, or any other administrative action, shall be carried out in a manner that provides due process protection to the person. | |||
| (d) | (d) [inserted: Authority with respect to the World Anti-Doping Agency.—] | |||
| (d)(1) | (1) [inserted: In general.—] | |||
| [inserted: The Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes’ Commission, shall—] | ||||
| (d)(1)(A) | (A) [inserted: ] | |||
| [inserted: use all available tools to ensure that—] | ||||
| (d)(1)(A)(i) | (i) [inserted: ] | |||
| [inserted: the World Anti-Doping Agency has a credible and independent governance model that provides for fair representation of the United States;] | ||||
| (d)(1)(A)(ii) | (ii) [inserted: ] | |||
| [inserted: the World Anti-Doping Agency fully implements all governance reforms, including a proper conflict-of-interest policy for all members of the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency; and] | ||||
| (d)(1)(A)(iii) | (iii) [inserted: ] | |||
| [inserted: independent athletes from the United States and other democratic countries, or representatives of such athletes, have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency;] | ||||
| (d)(1)(B) | (B) [inserted: ] | |||
| [inserted: demonstrate leadership within the global community;] | ||||
| (d)(1)(C) | (C) [inserted: ] | |||
| [inserted: have strict standards that work toward countering doping in every form, including by countering systemic fraud through doping involving—] | ||||
| (d)(1)(C)(i) | (i) [inserted: ] | |||
| [inserted: governmental law enforcement, intelligence, or anti-doping institutions;] | ||||
| (d)(1)(C)(ii) | (ii) [inserted: ] | |||
| [inserted: sporting organizations; or] | ||||
| (d)(1)(C)(iii) | (iii) [inserted: ] | |||
| [inserted: athlete support personnel; and] | ||||
| (d)(1)(D) | (D) [inserted: ] | |||
| [inserted: work collaboratively with democratic countries.] | ||||
| (d)(2) | (2) [inserted: Determination.—] | |||
| (d)(2)(A) | (A) [inserted: In general.—] | |||
| [inserted: Not later than 90 days after the date of the enactment of this subsection, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes’ Commission, shall make a determination as to whether the World Anti-Doping Agency—] | ||||
| (d)(2)(A)(i) | (i) [inserted: ] | |||
| [inserted: has a credible and independent governance model that provides for fair representation of the United States;] | ||||
| (d)(2)(A)(ii) | (ii) [inserted: ] | |||
| [inserted: fully implements all governance reforms, including a proper conflict-of-interest policy described in paragraph (1)(A)(ii); and] | ||||
| (d)(2)(A)(iii) | (iii) [inserted: ] | |||
| [inserted: allows independent athletes from the United States and other democratic countries, or representatives of such athletes, to have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency.] | ||||
| (d)(2)(B) | (B) [inserted: Accountability.—] | |||
| [inserted: In the case of a determination under subparagraph (A) that the World Anti-Doping Agency does not have such a governance model, has not fully implemented such governance reforms, or has not allowed decision-making roles described in clause (iii) of that subparagraph, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes’ Commission, shall—] | ||||
| (d)(2)(B)(i) | (i) [inserted: ] | |||
| [inserted: use all available tools to ensure that the United States has fair representation in the World Anti-Doping Agency, including—] | ||||
| (d)(2)(B)(i)(I) | (I) [inserted: ] | |||
| [inserted: on the Executive Committee;] | ||||
| (d)(2)(B)(i)(II) | (II) [inserted: ] | |||
| [inserted: on the Foundation Board; and] | ||||
| (d)(2)(B)(i)(III) | (III) [inserted: ] | |||
| [inserted: in all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency; and] | ||||
| (d)(2)(B)(ii) | (ii) [inserted: ] | |||
| [inserted: not later than 180 days after the date on which the determination under subparagraph (A) is made, issue a report that describes the barriers to participation and fair representation of the United States on the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency.] | ||||
| (d)(3) | (3) [inserted: Voluntary nonpayment of dues.—] | |||
| (d)(3)(A) | (A) [inserted: In general.—] | |||
| [inserted: In the case of a determination under paragraph (2)(A) that the World Anti-Doping Agency does not have a governance model that provides for fair representation of the United States, has not fully implemented governance reforms, or has not allowed decision-making roles described in clause (iii) of that subparagraph, the Office of National Drug Control Policy, in consultation with the appropriate committees of Congress, may voluntarily withhold up to the full amount of membership dues to the World Anti-Doping Agency.] | ||||
| (d)(3)(B) | (B) [inserted: Appropriate committees of Congress defined.—] | |||
| [inserted: In this paragraph, the term “appropriate committees of Congress” means—] | ||||
| (d)(3)(B)(i) | (i) [inserted: ] | |||
| [inserted: the Subcommittee on Consumer Protection, Product Safety, and Data Security of the Committee on Commerce, Science, and Transportation of the Senate (or a successor subcommittee);] | ||||
| (d)(3)(B)(ii) | (ii) [inserted: ] | |||
| [inserted: the Subcommittee on Financial Services and General Government of the Committee on Appropriations of the Senate (or a successor subcommittee);] | ||||
| (d)(3)(B)(iii) | (iii) [inserted: ] | |||
| [inserted: the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce of the House of Representatives (or a successor subcommittee); and] | ||||
| (d)(3)(B)(iv) | (iv) [inserted: ] | |||
| [inserted: the Subcommittee on Financial Services and General Government of the Committee on Appropriations of the House of Representatives (or a successor subcommittee).] | ||||
| (d)(4) | (4) [inserted: Spending plan.—] | |||
| [inserted: Not later than 30 days before the Office of National Drug Control Policy obligates funds to the World Anti-Doping Agency, the Office of National Drug Control Policy shall submit to the Committee on Appropriations of the Senate and the Committee on Appropriations of the House of Representatives a spending plan and explanation of proposed uses of such funds.] | ||||